Lincoln Alternative Strategies LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-27 09:15 am Purchase | 2025-08-20 | 13G | Calidi Biotherapeutics, Inc. CLDI | Lincoln Alternative Strategies LLC | 730,000 14.460% | 730,000 (New Position) | Filing |